Page last updated: 2024-11-13

sch 37224

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Sch 37224: structure in first source; inhibits leukotriene formation; inhibits thromboxane B2 release [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54680204
CHEMBL ID2105217
SCHEMBL ID125349
SCHEMBL ID125348
MeSH IDM0162157

Synonyms (23)

Synonym
sch-37224
pirodomast
2-hydroxy-1-phenyl-3-pyrrolidin-1-yl-1,8-naphthyridin-4-one
ULGABHCZIJXUFO-UHFFFAOYSA-N
CHEMBL2105217
unii-1s2eov9v3z
pirodomastum
108310-20-9
sch 37224
pirodomast [inn]
1s2eov9v3z ,
pirodomastum [inn-latin]
1-(1,2-dihydro-4-hydroxy-2-oxo-1-phenyl-1,8-naphthyridin-3-yl)pyrrolidinium
1,8-naphthyridin-2(1h)-one, 4-hydroxy-1-phenyl-3-(1-pyrrolidinyl)-
4-hydroxy-1-phenyl-3-(1-pyrrolidinyl)-1,8-naphthyridin-2(1h)-one
4-hydroxy-1-phenyl-3-(1-pyrrolidinyl)-1,8-naphthyridin-2-(1h)-one
SCHEMBL125349
SCHEMBL125348
DTXSID20148498
sch37224
Q27252828
4-hydroxy-1-phenyl-3-pyrrolidin-1-yl-1,8-naphthyridin-2-one
methyl3,6-dichloro-1-benzothiophene-2-carboxylate

Research Excerpts

Overview

Sch 37224 is an experimental antiallergy compound. It inhibits hyperventilation-induced bronchoconstriction (HIB) in guinea pigs and cold air bronchospasm in human asthmatics.

ExcerptReferenceRelevance
"Sch 37224 is an experimental antiallergy compound that inhibits hyperventilation-induced bronchoconstriction (HIB) in guinea pigs and cold air bronchospasm in human asthmatics. "( Sch 37224, an experimental antiallergy compound, inhibits the neuropeptide component of hyperventilation- and nicotine-induced bronchoconstriction in guinea pigs.
Anthes, J; Chapman, RW; Egan, RW; Greenfeder, S; Hey, JA; Kreutner, W; Mauser, PJ; Rasquinha, C; Sherwood, JE, 1997
)
3.18

Treatment

ExcerptReferenceRelevance
"Sch 37224 treatment reduced the peak immediate and peak late increases in SRL to 128 +/- 32 and 43 +/- 17%, respectively (both P less than .05 vs."( A leukotriene and thromboxane inhibitor (Sch 37224) blocks antigen-induced immediate and late responses and airway hyperresponsiveness in allergic sheep.
Abraham, WM; Garrido, R; Stevenson, JS, 1988
)
1.26

Dosage Studied

ExcerptRelevanceReference
" For these studies, base-line airway dose-response curves to histamine and carbachol were determined on the same day."( A leukotriene and thromboxane inhibitor (Sch 37224) blocks antigen-induced immediate and late responses and airway hyperresponsiveness in allergic sheep.
Abraham, WM; Garrido, R; Stevenson, JS, 1988
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.31 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]